H. Lundbeck A/S (HLBBF)
6.64
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
H. Lundbeck 1 Year Total Returns (Daily) : 24.27% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 24.27% |
| August 24, 2026 | 24.27% |
| August 21, 2026 | 24.27% |
| August 20, 2026 | 24.27% |
| August 19, 2026 | 24.27% |
| August 18, 2026 | 24.27% |
| August 17, 2026 | 24.27% |
| August 14, 2026 | 24.27% |
| August 13, 2026 | 13.22% |
| August 12, 2026 | 13.22% |
| August 11, 2026 | 21.25% |
| August 10, 2026 | 28.87% |
| August 07, 2026 | 28.87% |
| August 06, 2026 | 28.87% |
| August 05, 2026 | 28.87% |
| August 04, 2026 | 39.29% |
| August 03, 2026 | 39.29% |
| July 31, 2026 | 39.29% |
| July 30, 2026 | 39.29% |
| July 29, 2026 | 24.40% |
| July 28, 2026 | 24.40% |
| July 27, 2026 | 24.40% |
| July 24, 2026 | 27.81% |
| July 23, 2026 | 27.81% |
| July 22, 2026 | 28.64% |
| Date | Value |
|---|---|
| July 21, 2026 | 28.64% |
| July 20, 2026 | 14.49% |
| July 17, 2026 | 14.49% |
| July 16, 2026 | 14.49% |
| July 15, 2026 | 14.49% |
| July 14, 2026 | 13.54% |
| July 13, 2026 | 13.54% |
| July 10, 2026 | 13.54% |
| July 09, 2026 | 13.54% |
| July 08, 2026 | 13.54% |
| July 07, 2026 | 13.54% |
| July 06, 2026 | 13.54% |
| July 02, 2026 | 13.54% |
| July 01, 2026 | 27.33% |
| June 30, 2026 | 27.33% |
| June 29, 2026 | 27.33% |
| June 26, 2026 | 27.33% |
| June 25, 2026 | 27.33% |
| June 24, 2026 | 27.33% |
| June 23, 2026 | 27.33% |
| June 22, 2026 | 27.33% |
| June 18, 2026 | 18.68% |
| June 17, 2026 | 18.68% |
| June 16, 2026 | 31.09% |
| June 15, 2026 | 31.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Novo Nordisk A/S | -9.50% |
| ALK-Abello A/S | 31.99% |
| AstraZeneca PLC | 8.33% |
| ANI Pharmaceuticals, Inc. | -16.24% |
| Corcept Therapeutics, Inc. | 79.56% |